After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Ironwood Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Ironwood Pharmaceuticals Inc is $1.20B. A total of 2.4 million shares were traded on the day, compared to an average of 4.67M shares.
In the most recent transaction, Duane Jon R bought 6,920 shares of IRWD for 8.70 per share on Mar 06 ’24. After the transaction, the Director now owns 121,028 company shares. In a previous transaction on Mar 04 ’24, Emany Sravan Kumar bought 10,684 shares at 9.38 per share. IRWD shares that SVP, Chief Financial Officer owns now total 301,733.
Among the insiders who sold shares, MCCOURT Thomas A disposed of 177,164 shares on Feb 12 ’24 at a per-share price of $15.24. This resulted in the Chief Executive Officer holding 832,774 shares of IRWD after the transaction. In another insider transaction, John Minardo sold 47,380 shares at $15.24 per share on Feb 12 ’24. Company shares held by the Chief Legal Officer now total 224,796.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, IRWD has a high of $15.70 and a low of $7.68.
As of this writing, IRWD has an earnings estimate of $Ironwood Pharmaceuticals, Inc. per share for the current quarter. EPS was calculated based on a consensus of CrowdStrike Holdings, Inc. estimates, with a high estimate of $iRadimed Corporation per share and a lower estimate of $iShares Russell 1000 Value ETF.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IRWD’s latest balance sheet shows that the firm has $620.13M in Cash & Short Term Investments as of fiscal 2021. There were $475.80M in debt and $161.70M in liabilities at the time. Its Book Value Per Share was -$2.21, while its Total Shareholder’s Equity was $605.91M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IRWD is Buy with a score of 5.00.
